CHICAGO, Sept. 25, 2017 -- Allscripts (NASDAQ:MDRX) today announced that its Vice President of Investor Relations, Seth Frank will participate in meetings with institutional investors at the 2017 Bank of America Merrill Lynch Healthcare Supply Channel and HCIT One-on-One Conference, to be held Tuesday, September 26 in Boston, MA.
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Seth Frank
312-506-1213
[email protected]
Media:
Concetta Rasiarmos
312-447-2466
[email protected]


Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 



